美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BillionToOne, Inc.

108.94

+48.9481.57%

盘后：110.001.06+0.97%17:53 EST

成交量：142.81万

成交额：1.54亿

市值：47.95亿

市盈率：- -

高：123.84

开：100.00

低：95.00

收：60.00

52周最高：123.84

52周最低：95.00

股本：4,401.53万

流通股本：384.60万

量比：- -

换手率：37.13%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：-19.16

市盈率(LYR):- -

数据加载中...

总览公司新闻公告

BillionToOne(BLLN.US)登陆纳斯达克首日狂飙81.57% 市值升至近48亿美元

异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期

异动解读 | BillionToOne上市首日，股价盘中大涨66.67%

BUZZ-BillionToOne 首次登陆纳斯达克，开盘价将比发行价高出 33

重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元

BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股

分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元每股定价49至55美元

BillionToOne 在美国首次公开募股的目标估值超过 20 亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BLLN/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":108.94,"timestamp":1762462800000,"preClose":60,"halted":0,"volume":1428074,"hourTrading":{"tag":"盘后","latestPrice":110,"preClose":108.94,"latestTime":"17:53 EST","volume":24960,"amount":2634000.3455999997,"timestamp":1762469632948},"delay":0,"floatShares":3846000,"shares":44015300,"eps":0,"marketStatus":"盘后交易","change":48.94,"latestTime":"11-06 17:55:26 EST","open":100,"high":123.84,"low":95,"amount":153906691.02354,"amplitude":0.480667,"askPrice":110,"askSize":100,"bidPrice":108,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1762477200000},"marketStatusCode":4,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":60,"postHourTrading":{"tag":"盘后","latestPrice":110,"preClose":108.94,"latestTime":"17:53 EST","volume":24960,"amount":2634000.3455999997,"timestamp":1762469632948},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLLN\",,,,,undefined,":{"symbol":"BLLN","floatShares":3846000,"roa":"--","roe":"--","lyrEps":0,"shares":44015300,"dividePrice":0,"high":123.84,"amplitude":0.480667,"preClose":60,"low":95,"week52Low":95,"pbRate":"-19.16","psRate":"22.94","week52High":123.84,"institutionHeld":0,"latestPrice":108.94,"eps":0,"divideRate":0,"volume":1428074,"delay":0,"ttmEps":0,"open":100,"prevYearClose":60,"prevWeekClose":60,"prevMonthClose":60,"prevQuarterClose":60,"fiveDayClose":60,"twentyDayClose":60,"sixtyDayClose":60},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLLN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLLN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLLN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581491700","title":"BillionToOne(BLLN.US)登陆纳斯达克 首日狂飙81.57% 市值升至近48亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581491700","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581491700?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 06:00","pubTimestamp":1762466400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物分子诊断公司BillionToOne周四正式登陆纳斯达克，开盘股价暴涨，截至收盘，该股涨幅为81.57%，市值迅速升至近48亿美元，成为政府停摆背景下逆势上市的亮眼新股。BillionToOne此次发行价为60美元，开盘即跳涨至100美元，盘中最高逼近123.45美元。BillionToOne 目前位于加州门洛帕克，专注开发基于单分子测序技术的无创产前检测及肿瘤血液检测。在政府停摆持续、SEC审批程序受限的情况下，BillionToOne的成功上市被视为IPO市场回暖的重要信号。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SQQQ","NQmain","MNQmain","ARTL","QID","TSYW.SI","QLD","TQQQ","BLLN","USJW.SI","159632","03086",".IXIC","BK4007","NVIW.SI","PSQ","USAW.SI","BK1147"],"gpt_icon":1},{"id":"1191654904","title":"异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1191654904","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191654904?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne, Inc.今日在纳斯达克首次公开交易，盘中大涨66.67%，引起市场广泛关注。据悉，BillionToOne的股票开盘价为每股100美元，较60美元的发行价大幅上涨66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价高于预期区间。总部位于加利福尼亚州门洛帕克市的BillionToOne主要开发分子诊断测试，包括针对各种疾病的无创产前筛查和液体活检。BillionToOne的强劲debut表明投资者对其业务前景及生物科技行业整体保持乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"1131573131","title":"异动解读 | BillionToOne上市首日，股价盘中大涨66.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131573131","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131573131?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne今日在纳斯达克证券交易所首次亮相，股价表现亮眼，盘中大涨66.67%，引发市场广泛关注。据悉，BillionToOne的IPO发行价为每股60美元，而开盘价高达100美元，较发行价溢价66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价明显高于预期区间。此次成功上市不仅为BillionToOne带来了可观的融资，也反映了投资者对其业务前景的看好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"2581097986","title":"BUZZ-BillionToOne 首次登陆纳斯达克，开盘价将比发行价高出 33","url":"https://stock-news.laohu8.com/highlight/detail?id=2581097986","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581097986?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 23:33","pubTimestamp":1762443192,"startTime":"0","endTime":"0","summary":"11月6日 - ** 分子诊断公司BillionToOne的BLLN.O股票在纳斯达克首次上市时的开盘价将比发行价高出33.3%。** BLLN 开发分子诊断测试，包括针对各种疾病的无创产前筛查和液体活检。** 在截至 6 月 30 日的六个月中，BLLN 的收入激增 82%，达到 1.255 亿美元，净亏损缩小至 420 万美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4S3WI1TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BLLN","PIPR"],"gpt_icon":0},{"id":"2581036418","title":"重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581036418","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581036418?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 12:09","pubTimestamp":1762402178,"startTime":"0","endTime":"0","summary":"更新版 1-重发-更新 1-分子诊断公司 BillionToOne 在美国首次公开募股中融资 2.73 亿美元在第6段和第8-10段增加了细节和背景介绍。路透11月6日 - 分子诊断公司BillionToOne BLLN.O周三在美国首次公开募股中募集了2.731亿美元，股票定价高于市场范围。BillionToOne 是一家分子诊断公司，利用其单分子测序技术开发无创产前检查和肿瘤血液检查。BillionToOne 将在纳斯达克上市，股票代码为 \"BLLN\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL4T3WI0CG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIPR","BK4127","BLLN"],"gpt_icon":0},{"id":"1147084798","title":"BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股","url":"https://stock-news.laohu8.com/highlight/detail?id=1147084798","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147084798?lang=zh_cn&edition=fundamental","pubTime":"2025-10-29 18:02","pubTimestamp":1761732155,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0},{"id":"2576583836","title":"分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元 每股定价49至55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576583836","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576583836?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 15:38","pubTimestamp":1760945928,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，分子诊断公司BillionToOne公布了其首次公开募股的条款。按照拟议价格区间的中点计算，BillionToOne 的完全稀释后市值将达到 27 亿美元。2019 年，该公司推出了其首款产前产品 UNITY，这是首个利用游离 DNA 进行隐性遗传病胎儿风险评估的无创产前检测，无需父亲样本或侵入性操作。BillionToOne 成立于 2016 年，专注于产前筛查和癌症治疗监测领域，其核心Quantitative Counting Templates技术能以单碱基对精度检测DNA分子。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元 每股定价49至55美元","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BLLN"],"gpt_icon":0},{"id":"2576062746","title":"BillionToOne 在美国首次公开募股的目标估值超过 20 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576062746","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576062746?lang=zh_cn&edition=fundamental","pubTime":"2025-10-18 06:01","pubTimestamp":1760738513,"startTime":"0","endTime":"0","summary":"路透社10月17日 - 分子诊断公司BillionToOne BLLN.O周五表示，该公司在美国首次公开募股的目标估值高达24.2亿美元。此次发行正值美国首次公开募股活动反弹之际，扭转了今年早些时候因贸易政策不确定性抑制了IPO势头而出现的放缓趋势。BillionToOne 公司开发分子诊断测试，包括无创产前筛查和液体活检。该公司于本月早些时候提交了首次公开募股申请 ，并报告称 2025 年上半年的营收为 1.255 亿美元，而去年同期为 6900 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nL3S3VY1FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}